FDA approves Ipsen’s palovarotene for ultra-rare disease

The FDA gave a nod of approval to Ipsen’s treatment for the ultra-rare disease fibrodysplasia ossificans progressiva though regulators have expressed concerns at least twice about the safety and efficacy of the drug.

“For the first time doctors have an approved medicine available to them, shown to reduce the formation…
Click here to view original post